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Although IL-1  was originally defined (1) as a  monocyte/macrophage product 
that stimulates lymphocyte proliferation in vitro, it has become clear that a closely 
related or identical substance is also produced by other cell types and has actions 
on a  variety of nonlymphoid target tissues (2-4). One such target tissue appears 
to  be  bone,  which  is  stimulated  by  a  mononuclear  cell  factor  with  IL-l-like 
properties  to  increased  osteoclastic  resorption  in  organ  culture  (5,  6).  Bone 
resorption is often a feature of inflammatory diseases such as rheumatoid arthritis 
and periodontal disease, and IL-1 production by inflammatory tissue may be the 
mechanism by which inflammatory osteolysis is effected. We postulated that IL- 
l  may also have a  role in the physiology of bone resorption. We have found (7) 
that agents which stimulate osteoclastic bone resorption in intact bone appear to 
have  no  direct  stimulatory  effect  on  osteoclasts.  This  infers  that  resorption 
stimulators  act  primarily  on  another bone  cell  type,  which  is  induced,  by the 
presence of these agents, to stimulate osteoclastic resorption: IL-1  might repre- 
sent the unknown mediator of osteoclastic stimulation. We therefore elected to 
analyze the mechanism by which IL-1 induces bone resorption, in an attempt to 
identify the target cell type and to clarify the role of IL-1 in the pathophysiology 
of bone resorption. 
Materials and Methods 
Porcine IL-1 of pI 5.0 (originally called catabolin because of its ability to cause cartilage 
degradation) was purified to homogeneity from pig mononuclear leukocytes as previously 
described (8, 9).  Hepes-buffered medium  199 (Flow Laboratories, Irvine, United King- 
dom) was used for cell isolation, and phosphate-free Eagle's MEM  (Flow  Laboratories), 
supplemented with  100  IU/ml  benzyl penicillin (Glaxo,  Middlesex,  United  Kingdom), 
100  eg/ml  streptomycin (Glaxo), and  10%  heat-inactivated FCS  (Gibco Laboratories, 
Uxbridge, United Kingdom) used for subsequent incubations. 
Slices of human cortical bone (3 x  3 x  0.1  mm) were cut with a low-speed saw (Isomet, 
Buehler, IL) longitudinally from the femurs of patients who died without evidence of 
bone disease.  Bone slices were ultrasonicated for 30 min, washed in acetone and ethanol, 
and stored dry at room temperature. 
Calvarial cells were obtained by collagenase digestion of calvariae from neonatal female 
Wistar rats killed by decapitation within 48 h of birth. The calvariae were removed and 
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dissected free of periosteal tissue before incubation at 37°C  in medium  199 with colla- 
genase (1  mg/ml; type II; Sigma Chemical Co., St. Louis, MO) for 15 min. The calvariae 
were washed  in  medium  199  and returned to fresh collagenase for 90  min. After mild 
agitation with a  plastic pipette, the resultant cell suspension was washed, resuspended in 
MEM/FCS, and  incubated in air at 37°C  in  50-mm  Falcon tissue culture dishes.  Upon 
reaching confluence after 3-7 d, the cells were removed with  1 mM EDTA in Ca2+-free 
PBS, washed, and resuspended in 3.0 ml of MEM/FCS at l0  s cells/ml. 
Samples of cell suspension  settled onto  6-mm glass coverslips were  fixed for  10  s  in 
10%  formal calcium. Alkaline phosphatase histochemistry revealed that the majority of 
cells were  alkaline phosphatase-positive (10).  500  t~l of calvarial cell  suspension  were 
added to a  16-mm-diam well of a  Linbro (Sterilin, Teddington, United Kingdom) plate 
containing four bone slices in  1.5 ml MEM/FCS, and the cultu÷es were incubated for 24 
h in 5% CO2. The remainder of the cell suspension was used as described below. 
Osteoclasts were disaggregated as previously described (11).  Female Wistar rats were 
decapitated within 48 h of birth. Tibias and femurs from one animal were dissected free 
of adherent soft tissue and curetted into 1.5 ml of medium  199. The resulting fragments 
were vigorously agitated with a  plastic pipettte. The cell suspension released was added 
to  16 bone slices in a  well of a  Sterilin  100  x  18-ram multiwell dish, and the cells were 
allowed to settle at 37 °C in air for 15 min. The bone slices were then washed in Medium 
199.  Groups of four bone slices were transferred to each of four  16-mm-diam wells of a 
Linbro plate containing 1.5 ml of MEM/FCS. 500 #1 of calvarial cell suspension was added 
to two wells, and 500 #1 of MEM/FCS was added to the remaining two wells. The resulting 
cultures were incubated for 24 h in the presence or absence of IL-1 (2 ng/ml). 
Bone slices were fixed in 1% glutaraldehyde and stained with toluidine blue (10 mg/ml) 
for 45 s. Osteoclasts were identified as large multinucleate cells of complex morphology. 
All multinucleate ceils were counted. Mononuclear cell density was estimated as the mean 
number of cells counted  in  10  random fields at ×  250  magnification using an eyepiece 
graticule. 
To measure the volume of bone resorbed, the cells were removed from the bone slices 
by immersion in  10% NaOCI for 20 min. The slices were washed, dehydrated in ethanol, 
air dried, and sputter coated with gold. The specimens were inspected in a  Cambridge 
S90B scanning electron microscope. The number of osteoclastic excavations were counted 
and  the outline of each  traced from  the  monitor.  The  area of each pit was calculated 
using a  digitizing tablet input into an Apple IIe microcomputer. The depth of the first 
eight  lacunae  observed  from  each  treatment  and  corresponding  control  group  was 
measured by parallax change  in the position of a  point at the center of the lacunae in 
stereo paired photographs (tilt, 10 o; magnification, ×  2,000 [ 12]). The approximate total 
volume of bone resorbed was assessed from the total surface area of resorption lacunae 
and mean pit depth (13). Student's t test was used in tests for statistical significance. 
For each of six experiments, the mean number and size of resorption lacunae produced 
on a group of four I L-1-treated bone slices were expressed as a ratio against a correspond- 
ing group of four control bone slices incubated in the absence of IL-1. 
As additional controls, calvarial cells were settled onto bone slices as described above 
but without previous addition of osteoclasts, and were incubated with or without IL-1 for 
24 h. 
Effect  of Other Cell  Types  on  Osteoclastic  Bone Resorption.  Clonal osteoblast-like UMR 
106 cells, grown to confluence on Nunclon 50-ml tissue culture flasks (Gibco, Uxbridge, 
United Kingdom) in MEM/FCS, were removed by 15 min incubation in  1 mM EDTA in 
Ca2+-free PBS, washed, and resuspended (106 cells/ml) in MEM/FCS. 
Skin fibroblasts were obtained by collagenase digestion of neonatal rat skin. 3 cm  2 of 
neonatal rat skin  were  incubated for 60  rain  in collagenase (1  mg/ml in  medium  199), 
and the resulting cell suspension was washed twice and incubated in MEM/FCS in 60-mm 
Nunclon tissue culture dishes until confluent (3-7 d). Fibroblast suspensions were prepared 
by exposing these cells to  1 mM EDTA in Ca2+-free PBS for 30 min before washing and 
resuspending in MEM/FCS (10 6 cells/ml). 
For each of four experiments, osteoclasts were sedimented onto bone slices as above. 106  OSTEOCLASTIC BONE  RESORPTION 
Groups of four bone slices were placed in three  16-mm-diam wells ofa Linbro plate, each 
containing 1.5 ml MEM/FCS.  500 #1 of UMR 106 cell suspension was added to one well, 
500 t~l of skin fibroblast suspension was added to the second well, and 500 ul of MEM/FCS 
to  the  third.  The  bone  slices  were  incubated  for  24  h,  and  cell  numbers  and  bone 
resorption were quantified as above. 
Effects of Other Cell Types on Osteoclastic  Response to IL-I.  For each of five experiments, 
osteoclasts were sedimented onto bone slices.  Groups of four bone slices were placed into 
two 16-mm-diam wells of a Linbro plate containing 1.5 ml MEM/FCS.  500 •l  aliquots of 
UMR 106 cell suspension were added to eacb well.  IL-1 (1  ng/ml) was added to one  16- 
mm-diam well, while vehicle was added to the other well. As additional controls, 500 ul 
aliquots of UMR suspension were added to groups of four bone slices  in the absence of 
osteoclasts, and in the presence or absence of 1L-1  (1 ng/ml). 
After incubation for 24 h, cell numbers and bone resorption were quantified as before. 
These  experiments  were  repeated  substituting  skin  fibroblasts  for  UMR cells,  cultures 
being  maintained  for  24  h  in  the  presence  or  absence  of  IL-I  (2  ng/ml  for  four 
experiments; 0.1  ng/ml in 6 experiments),  with the numbers of cells and bone resorption 
quantified as before. 
Sensitivity  of  Osteoclast-Calvarial  Cell  Cocultures  to  IL-1,  and  Effect  of  lndometha- 
cin.  Disaggregated  osteoclast  cultures  were  prepared  by sedimenting  osteoclasts  onto 
bone slices as above. Groups of four bone slices with adherent osteoclasts were each placed 
into 16-mm-diam wells of a Linbro plate in  1.5 ml MEM/FCS, and 500 ~1 of calvarial cell 
suspension (106 cells/ml) were added. The plates were incubated for 24 h in the presence 
or absence of IL-1 (3 pg/ml to 2 ng/ml). 
Similarly,  four experiments  were  performed  in  which  groups of four calvarial  cell- 
osteoclast cocultures, prepared as above, were incubated in the presence of indomethacin 
(10  ug/ml),  IL-1  (1  ng/ml),  indomethacin  (10  ug/ml)  plus  IL-1  (1  ng/ml),  and  in  the 
absence of both these agents to investigate the role of prostaglandin  synthesis in  IL-l's 
action upon bone. 
To  test  for the  existence  of a  stable  diffusible  factor produced  by calvarial  cells  in 
response to I L-l, for each of five experiments, osteoclasts were sedimented onto 16 bone 
slices in the well of a Sterilin  100 x  18-mm multiwell dish.  Eight of the bone slices were 
then  transferred  to each of two  16-mm-diam wells of a  Linbro plate containing  1.5  ml 
MEM/FCS, and the osteoclasts were permitted to spread for !  h.  500 ~1 of calvarial cell 
suspension (prepared as above) were added to one well, 500 ~1 MEM/FCS to the remaining 
well, and the calvarial cells were allowed to settle for 6 h. Four bone slices  with adhering 
mixed osteoclast and calvarial cell cocultures, and four bone slices with adherent disag- 
gregated osteoclasts were carefully placed into each of two wells of a  Sterilin  100 x  18- 
ram  multiwell  dish  containing  2.0  ml  MEM/FCS  and  incubated  in  the  presence  and 
absence  of IL-1  (1  ng/ml)  for  24  h  before  cell  counting  and  quantification  of bone 
resorption as before. 
Results 
Bone  slices  incubated  with  preparations  of  disaggregated  osteoclastic  cells 
alone  showed a  sparse  population  of (multinucleate)  osteoclasts  (5  +  0.8  osteo- 
clasts  per bone slice,  mean  +  SEM;  55  cells/cm 2) and  mononuclear cells  (mean 
cell density,  3  +  0.5  x  10 s cells/cm2).  Such populations showed no response  to 
IL-1,  as  assessed  by  the  numbers  of  resorption  lacunae  formed,  their  mean 
volume, or the total  bone resorbed per slice (Fig.  1). 
Calvarial  cells,  UMR  I06 and  fibroblastic  cell  suspensions  settled  onto  bone 
slices  adhered  within  a  few  hours and  formed  contiguous  sheets  of well-spread 
cells. Cell densities are given in Table I. None of these mononuclear cells altered 
the  level of osteoclasis in mixed  mononuclear cell-osteoclast  cocultures as com- 
pared  to  that  produced  by  disaggregated  osteoclasts  alone.  However,  in  the 107 
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FIGURE  1.  Effect of IL-I on bone resorption by disaggregated osteoclasts and calvarial cell- 
osteoclast cocuhures after  24  h  of incubation.  Results expressed as ratios (mean ±  SEM) of 
bone resorption in the presence of I L-1 (2 ng/ml) to bone resorption in the corresponding I L- 
l-free control  group (six experiments). Black  bars,  total  volume of bone resorbed per bone 
slice; open  bars,  total  plan surface area of excavations; crosshatched bars,  mean excavation 
depth;  stippled  bars,  mean  plan  excavation  area.  Asterisks denote  groups  with  p  <  0.01 
Student's t test. 
TABLE  I 
Dose- and Mononuclear Cell-dependence  of IL-l-induced Bone Resorption  by 
Disaggregated Osteoclast Populations 
Cell types cocuhured 
Number of ex-  Total plan area re-  IL- 1 treat-  cavations per  Number of  sorbed per bone slice  merit  bone slice 
(pg/ml)  experiments  (treated/control  (treated/control 
± SEM)  _+ SEM) 
Calvarial ceils +  osteoclasts  3  4  1.1  +  0.13  1.2 +  0.18 
10  4  1.5 ±  0.23  1.3 -+ 0.24 
30  5  1.6 +  0.1  1.8 ±  0.28* 
100  4  2.0 -  0.23*  2.4 ±  0.12 ~ 
1,000  4  2.8 -+ 0.36*  3.8 +  0.38  § 
2,000  5  2.7 +  0.5"  3.8 ±  0.42  ~ 
UMR  106 +  osteoclasts  1,000  7  3.9 ±  0.48*  3.23 -  0.65* 
Fibroblasts +  osteoclasts  100  6  0.82 ±  0.1  0.76 ±  0.17 
2,000  4  ! .03 ±  0.49  1.24 +  0.59 
Results are expressed as ratios (mean +  SEM) of bone resorption over a  24-h incubation period, in 
groups of four mixed mononuclear cell-osteoclast cocuhures in the presence or absence of 1L-1. 
Mononuclear cell densities: calvarial cell-osteoclast,  34  +  4  ×  10  ~ cells/cm~; fibroblast-osteoclast, 
49 ±  3  g  10  ~ cells/cm~; UMR  106-osteoclast, 60 ×  103 cells/era  2 
* p  <  0.05. 
*p<0.01. 
§ p  <  0.005, Student's t test. 108  OSTEOCLASTIC BONE RESORPTION 
TABLE II 
Number, Plan Area, Depth, and Volume of Excavations Formed by Mixed Mononuclear Cell- 
Osteoblast Cocultures During 24-h Incubation Period in Presence or Absence of  lL-1 
Incubation conditions 
Total plan area  Total volume 
Plan area (,urn ~)  (,urn ~ X  10  -~)  Mean excava-  (~m ~ ×  10  -~) of  Excavations  of individual 
per slice  excavations  resorbed per  tion depth  bone resorbed 
bone slice  (#m +  SEM)  per bone slice 
(mean  +  SEM)  (mean ___ SEM)  (mean ±  SEM)  (mean ±  SEM) 
Caivarial cells +  osteoclasts  23 -+ 2.7*  928 ±  99  22 -+ 3,4*  5.7 --+ 0,8  84.4 ±  12.3* 
+  IL-1  (1  ng/ml) 
Calvarial cells +  osteoclasts  7.5 ±  1.2  761  _  86  5.6 ±  1.1  5.0 ±  0.8  18.5 _+ 3.6 
+  vehicle 
UMRI06  +  osteoclasts +  12.4 +  1.6"  1,433 ±  109  17.5 ±  2.4*  5.1  ±  0.9  59.5 +  8.:3* 
IL-I  (1  ng/ml) 
UMR106 +  osteoclasts +  3.5 +  0.7  1,463 -+ 261  4.3 +  0.9  5.3 _+  1.2  15 +  3.0 
vehicle 
Fibroblasts +  osteoclasts +  5.0 ±  0.8  1,154 :i: 344  3.4 +  0.7  4.8 ±  2,9  10.9 ±  2.1 
IE-I  (1  ng/ml) 
Fibroblasts +  osteoclasts +  5.2 -  1.1  1,025 ±  327  5.4 ±  1.8  3,8 ±  1.2  13.4 ±  4.6 
vehicle 
* p <  0.0125; Student's t test. 
presence of calvarial cells or UMR 106 cells, disaggregated osteoclasts responded 
to IL-1 at >_30 pg/ml, showing a dose-dependent, statistically significant increase 
in  the  total  area  of bone  resorbed  (Table  I).  None  of the  mononuclear  cell 
populations  incubated  without  mechanically-disaggregated  osteoclasts  showed 
any  morphological  evidence  of  bone  resorption.  These  results  indicate  that 
addition  of such  osteoblastic cells confers IL-1  responsiveness  upon  otherwise 
nonresponsive populations of disaggregated osteoclasts (Fig.  1 and Table II). 
In contrast, osteoclast-skin flbroblast cocultures failed to respond to IL-1 with 
increased bone resorption when compared to IL-l-free control cultures (Tables 
I and II). 
Indomethacin  (10 #g/ml)  did  not alter  the  level  of osteoclasis produced  by 
mixed calvarial  cell-osteoclast cocultures,  nor did it modify the  stimulation  of 
bone resorption induced in these cultures by IL-1 (1 ng/ml) (Table III). 
Mixed calvarial cell-osteoclast cocultures and disaggregated osteoclast cultures 
were maintained in the same culture volume, in the presence and absence of IL- 
l  (1  ng/ml),  so that the disaggregated osteoclast cultures would be exposed to 
any  stable  diffusible  factors  released  in  response  to  IL-1  by  calvarial  cells. 
Calvarial cell-osteoclast cocuitures treated with IL-1  responded with a fourfold 
stimulation of bone resorption when compared to non-IL-l-treated controls.  In 
contrast,  disaggregated osteoclast cultures from IL-l-treated wells (in the same 
dish  with,  but separated  by  I  mm  from bone slices upon which  were calvarial 
cells and osteoclasts) displayed no increase in resorption compared to non-IL-1- 
treated controls (Table IV). 
The osteoclasts in our cultures excavate clearly delineated resorption lacunae. 
Fig.  2 shows the distribution  of the proportion  of pits of a  given surface area. 
This  distribution  was unaltered  when  total  bone resorption  was stimulated  by 
IL-1.  Fig.  1 and  Table  II  indicate  that  the  mean  surface  area  and  depth  of 
resorption lacunae were uninfluenced by IL-1. The increased resorption induced 
by  IL-1  appears  therefore  to  result  from  increased  numbers  of  resorption 
lacunae. THOMSON  ET  AL. 
TABLE  III 
Effect of lndomethacin  (10 #g/ml) on IL-I (1 ng/ml) Responsiveness of 
Calvarial  Cell-Osteoclast Cocultures 
109 
Culture conditions compared  Number of excava-  Plan area ofindi-  Total plan area re- 
tions per slice  vidual excavations  sorbed per slice 
lndomethacin vs. vehicle  0.94 ±  0.1  1.04 ±  0.2  1.1  ±  0.25 
IL-1 vs. vehicle  2.9 ±  0.34  1.19 ±  0.2  3.8 ±  0.46 
IL-1  +  indomethacin vs. vehicle  2.6 ±  0.33  1.42 ±  0.12  4.0 ±  0.5 
IL-1 +  indomethacin vs. IL-1  0.92 ±  0.06  1.37 ±  0.19  1.06 ±  0.15 
Results expressed as ratios  (treated/control,  mean  ±  SEM)  of bone  resorption  by groups of four 
bone slices to bone resorption by appropriate control groups of bone slices in four experiments. 
TABLE  IV 
Number and Plan Area of Excavations Formed by Disaggregated Osteoclast and 
Mixed Calvarial  Cell-Osteoclast Cocultures Incubated in the Same Volume in 
Presence and Absence of lL-I 
Incubation conditions 
Plan area (um  ~)  Total plan area 
Excavations  of individual  (t~m  2) resorbed 
per bone slice  excavations  per bone slice 
(mean _  SEM)  (mean ±  SEM)  (mean 4- SEM) 
Number of 
bone slices 
Osteoclasts +  vehicle 
Calvarial cells +  osteoclasts 
+  vehicle 
Osteoclasts +  IL-1 
(1  ng/ml) 
Calvarial cells +  osteoclasts 
+  IL-I 
5.6 4- 1.0  1,229 --- 207  5,451  +  1,200 
3.4 +  0.55  1,334 +  151  4,450 4- 875 
3.7 +  0.7  1,201  ±  221  3,582 +  796 
21  +  2.1"  1,484 +  189  20,293 +  4,086* 
20 
20 
20 
21 
* p  <  0.001  Student's t test. 
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FIGURE  2.  EffectoflL-1 (1 ng/ml; 3 pg/ml) on the size distribution ofosteoclastic excavations 
formed  by  mixed calvarial  cell-osteoclast  cultures.  &,  IL-1,  1  ng/ml; Q,  IL-I  3  pg/ml;  O, 
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Discussion 
We have found that I L-1 does not stimulate resorption by osteoclasts disaggre- 
gated  from  bone  and  widely dispersed  at  low  cell  density.  However,  in  the 
presence of calvarial cells  or cloned osteosarcoma cells,  IL-1  effected a  3.8  +_ 
0.38-fold increase in osteoclastic bone resorption,  with statistically significant 
enhancement at concentrations of _>30 pg/ml.  Since the osteoblast-containing 
populations themselves did not resorb bone, even in the presence of IL-1, these 
results  imply  that  osteoblastic  cells  are  induced  by  the  presence  of IL-I  to 
stimulate osteoclastic bone resorption. 
The mechanism by which osteoblastic cells stimulated osteoclasts did not seem 
to depend on  PG synthesis; nor could we detect a  diffusible substance  in  the 
medium of stimulated cocultures. Osteoclastic stimulation was observed only on 
bone  slices  on  which  osteoblasts and  osteoclasts were  both  present,  and  this 
indicates a short-range diffusible mediator or a contact-dependent interaction. 
Skin fibroblasts were unable to duplicate the osteoblast-mediated IL-1 stimu- 
lation of osteoclastic bone resorption. We do not know whether this failure was 
in the afferent or efferent limb of the IL-1  response. However, osteoblasts and 
osteoclasts are closely associated on bone surfaces in intact bone, and in view of 
the short-range nature of the interaction we have demonstrated, the degree of 
specificity for the interaction between osteoblasts and osteoclasts in the presence 
of IL-1  may owe less to specificity of action on a  given cell  type and more to 
close spatial juxtaposition of the interacting cells. 
Increased resorption in the presence of IL-1 was effected by an increase in the 
number  of excavations,  without  significant  increase  in  the  volume  of each 
excavation. One explanation for the increased number of excavations may be 
induction  by  IL-1  of an  increased  proportion  of osteoclasts  to  resorb  bone. 
Another, which would also account for the failure of IL-1  to increase mean pit 
volume,  is  that  IL-1  may induce  less  mature,  smaller  or  even  mononuclear 
osteoclastic cells to resorb bone: some of the mononuclear cells in disaggregated 
osteoclastic populations do show phenotypic similarities with osteoclasts (11),  but 
these cells  are not at present readily distinguished from nonosteoclastic mono- 
nuclear cells.  Alternatively, osteoclasts may be  induced by  IL-1  to  undertake 
multiple episodes of bone resorption. We previously noted in time-lapse obser- 
vations that osteoc]astic motility tends not to be constant, but intermittent, with 
episodes  of relative quiescence  interspersed  by bursts  of cytoplasmic motility 
(14).  This episodic behavior may account for the multiple discrete excavations 
frequently observed after incubation of osteoclasts on bone (15,  16), and IL-1 
may act by reducing the time interval between episodes of osteoclastic resorptive 
activity. It is of interest that the dominant effect of inhibitors of bone resorption 
on  disaggregated osteoclasts was  also  large accounted for by a  change in  the 
number of excavations induced, with little or no decrease in the volume of bone 
resorbed in each concavity (7). 
The extreme sensitivity of osteoblast-osteoclast cultures to the presence of 1L- 
1 suggests that the agent may play a role in bone resorption in vivo. Our results 
seem  to  exclude  a  role  of IL-1  as  a  mediator  of osteoblastic  stimulation  of 
osteoclastic resorption.  Because IL-1  is produced by macrophages and induces 
bone resorption, it may be instrumental in the local osteolysis of inflammatory THOMSON ET  AL.  111 
disease. However, it is difficult to discern a clear adaptive role for local osteolysis 
in inflammation;  this may not be its primary role.  One role of IL-1  appears to 
be  as  an  agent  of the  systemic  host  response  to  inflammatory  and  injurious 
stimuli: it is pyrogenic (17-19), and is associated with generalized skeletal muscle 
catabolism  in  fever  (20).  Enhanced  bone  resorption,  by  effecting  a  shift  in 
systemic skeletal homeostasis towards catabolism, may be another aspect of the 
role of I L-1 in the adaptive host response to injury. Another theoretical possibility 
is that macrophages play a physiological role, through  local IL-1 production, in 
the control  of bone remodelling.  However, cell types other than  mononuclear 
phagocytes, and including periosteal fibroblasts, are known to produce cytokines 
with  IL-l-like properties (21,  22), and a  further possibility is that  IL-1  may be 
produced  by  bone  cells  as  one  of  the  local  mediators  of  the  physiological 
interactions  of bone cells.  Inflammatory osteolysis may then be explicable as a 
perturbation of normal physiological mechanisms through the immigration  into 
bone of inflammatory cells that similarly use IL-1 as a  local mediator of cell-cell 
interactions.  Resolution  of these  various possibilities requires  identification  of 
the  bone cell type that  produces  IL-1, and  of the control  of its production  in 
response to environmental agents. 
Summary 
A monocyte-derived factor with IL-l-like properties has recently been shown 
to cause resorption of bone in organ culture. We have investigated the action of 
IL-1  on  disaggregated  populations  of osteoclasts,  incubated  alone  or  in  the 
presence of osteoblastic cells, in an attempt to identify the target cell for IL-1 in 
bone, and to elucidate the mechanism by which IL-1 induces osteoclastic resorp- 
tion. Osteoclasts were disaggregated from neonatal rat long bones and incubated 
on slices of human  femoral cortical bone.  Under these conditions,  the majority 
of osteoclasts form distinctive excavations in the bone surface within  24 h,  the 
volume  of which  can  be  quantified  by  computer-assisted  morphometric  and 
stereophotogrammetic  techniques.  IL-1  had  no  effect on  bone  resorption  by 
osteoclasts alone, but when incubated in the presence of calvarial cells or cloned 
osteosarcoma cells,  it  induced  a  3.8  (+0.38)-fold  increase  in osteoclastic bone 
resorption,  with significant enhancement  at concentrations of >30 pg/ml.  The 
osteoblastic populations themselves did not resorb bone. 
The mechanism by which osteoblastic cells stimulate osteoclasts did not appear 
to depend upon  PG synthesis; nor could we detect a diffusible substance in the 
medium  of stimulated  cocultures.  These  results  indicate  that  IL-1  stimulates 
bone resorption through  a primary action on osteoblasts, which are induced by 
IL-1 to transmit a short-range signal that stimulates osteoclastic bone resorption. 
We thank Mrs. C. Snalune  for typing the manuscript. 
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